iiinova — where your digital self keeps evolving

Christophe Masset @c-masset.bsky.social · 09/01/2026

Very proud to share this huge french collaborative work that we led on the interest of RTX for relapses prevention in adult INS !🔥

001

Reposted by Christophe Masset

American Journal of Kidney Diseases @ajkd.bsky.social · 16/12/2025

Response to Rituximab as a Maintenance Therapy in Adult Idiopathic Nephrotic Syndrome: A French Multicenter Cohort Study bit.ly/4pDdIsn

Relapses per patient and per year during the 2 years preceding and the 2 years following rituximab introduction. Five patients with unknown INS subtype were excluded from the analysis of MCD and FSGS patients. Three patients with unknown steroid-sensitivity were excluded from the analysis of SSNS and SRNS patients. Number of relapses per patient and per year are represented as mean +/- SD. FSGS, primary focal segmental glomerulosclerosis; MCD, minimal change disease; SRNS, steroid-resistant nephrotic syndrome; SSNS, steroid-sensitive nephrotic syndrome. ***: p < 0.001.

041

Reposted by Christophe Masset

Transplant International @transpl-int.bsky.social · 01/07/2025

There was a fierce competition among the participants of the Best Poster Selection. The finalists were Leonie van Leeuwen, PhD, Alex Daniel, Rebecca Panconesi, Alexandre Hertig and Fayyad Jaradat. In the end Alexandre Hertig convinced the jury the most. Congratulations to everyone!! #ESOTcongress

021

Reposted by Christophe Masset

Transplant International @transpl-int.bsky.social · 05/04/2025

VIDEO ABSTRACT "Indications and Long-Term Outcomes of Using Mycophenolate Mofetil Monotherapy in Substitution for Calcineurin Inhibitors in Liver Transplantation" The article here: shorturl.at/qumve #mycophenolate #monotherapy #liver #transplantation #video #abstract @esottransplant.bsky.social

011

Reposted by Christophe Masset

Transplant International @transpl-int.bsky.social · 20/03/2025

VIDEO ABSTRACT "γδ T Cells’ Role in Donor-Specific Antibody Generation: Insights From Transplant Recipients and Experimental Models" Read the article here: shorturl.at/qK3SU #tcell #kidney #transplant #donor #antibody @esottransplant.bsky.social @sorbonne-universite.fr @univbordeaux.bsky.social

022

Reposted by Christophe Masset

Thierry Berney @berneyyy.bsky.social · 25/02/2025

A single IS drug to preserve your kidneys! It is in Transplant International !@transpl-int.bsky.social

022

Reposted by Christophe Masset

Transplant International @transpl-int.bsky.social · 10/03/2025

📢 Join our next Transplant International Journal Club! We’ll dive into a Delphi consensus on imlifidase for HLA-incompatible kidney transplantation in highly sensitized patients. 🏥💉 #Transplantation #KidneyTransplant (1/6) Register here: go.esot.org/ti_jc17march

156

Reposted by Christophe Masset

NEJM.org @nejm.org · 22/02/2025

A 𝐡𝐲𝐩𝐞𝐫𝐢𝐦𝐦𝐮𝐧𝐞 𝐚𝐜𝐮𝐭𝐞 𝐫𝐞𝐣𝐞𝐜𝐭𝐢𝐨𝐧 is a rejection of a transplanted graft within 48 hours after transplantation, owing to preexisting cytotoxic antibodies in the recipient that bind antigen on the graft, which leads to coagulation, ischemia, and necrosis. #MedSky #ScienceSky

Visual representation of "hyperimmune acute rejection"

15810

Reposted by Christophe Masset

Emilie Cornec-Le Gall @ecorneclegall.bsky.social · 19/02/2025

[J-1 mois] La Société Francophone de Transplantation se mobilise une nouvelle fois pour la Course du Cœur, du 19 au 23 mars ! 💚 La Course du Cœur est un événement sportif unique en son genre organisé par l' Association @TransFormeDON lacourseducoeur.com

lacourseducoeur.com

La course du coeur - Accueil

043

Christophe Masset @c-masset.bsky.social · 22/11/2024

First post here... Leaving X, as many of you guys !

010